Papers
Topics
Authors
Recent
Assistant
AI Research Assistant
Well-researched responses based on relevant abstracts and paper content.
Custom Instructions Pro
Preferences or requirements that you'd like Emergent Mind to consider when generating responses.
Gemini 2.5 Flash
Gemini 2.5 Flash 79 tok/s
Gemini 2.5 Pro 60 tok/s Pro
GPT-5 Medium 25 tok/s Pro
GPT-5 High 29 tok/s Pro
GPT-4o 117 tok/s Pro
Kimi K2 201 tok/s Pro
GPT OSS 120B 466 tok/s Pro
Claude Sonnet 4.5 37 tok/s Pro
2000 character limit reached

Brain Tumor Segmentation in Sub-Sahara Africa with Advanced Transformer and ConvNet Methods: Fine-Tuning, Data Mixing and Ensembling (2508.10905v1)

Published 29 Jul 2025 in q-bio.QM

Abstract: Brain tumors are among the deadliest cancers worldwide, with particularly devastating impact in Sub-Saharan Africa (SSA) where limited access to medical imaging infrastructure and expertise often delays diagnosis and treatment planning. Accurate brain tumor segmentation is crucial for treatment planning, surgical guidance, and monitoring disease progression, yet manual segmentation is time-consuming and subject to inter-observer variability. Recent advances in deep learning, based on Convolutional Neural Networks (CNNs) and Transformers have demonstrated significant potential in automating this critical task. This study evaluates three state-of-the-art architectures, SwinUNETR-v2, nnUNet, and MedNeXt for automated brain tumor segmentation in multi-parametric Magnetic Resonance Imaging (MRI) scans. We trained our models on the BraTS-Africa 2024 and BraTS2021 datasets, and performed validation on the BraTS-Africa 2024 validation set. We observed that training on a mixed dataset (BraTS-Africa 2024 and BraTS2021) did not yield improved performance on the SSA validation set in all tumor regions compared to training solely on SSA data with well-validated methods. Ensembling predictions from different models also lead to notable performance increases. Our best-performing model, a finetuned MedNeXt, achieved an average lesion-wise Dice score of 0.84, with individual scores of 0.81 (enhancing tumor), 0.81 (tumor core), and 0.91 (whole tumor). While further improvements are expected with extended training and larger datasets, these results demonstrate the feasibility of deploying deep learning for reliable tumor segmentation in resource-limited settings. We further highlight the need to improve local data acquisition protocols to support the development of clinically relevant, region-specific AI tools.

Summary

We haven't generated a summary for this paper yet.

Lightbulb Streamline Icon: https://streamlinehq.com

Continue Learning

We haven't generated follow-up questions for this paper yet.

List To Do Tasks Checklist Streamline Icon: https://streamlinehq.com

Collections

Sign up for free to add this paper to one or more collections.

X Twitter Logo Streamline Icon: https://streamlinehq.com

Tweets

This paper has been mentioned in 1 post and received 0 likes.